Titan PharmaceuticalsTTNP
13F holders, Q2 2024 (June 30)18holders +1
1new positions
0sold out
$5.57avg. 13F price*
At the end of Q2 2024, 18 institutions reported holding Titan Pharmaceuticals Inc. (TTNP) in their 13F filings, up 1 from Q1 2024. 1 opened new positions and 0 sold out. The largest holders were Truist Financial Corp. ($174K), Tower Research Capital LLC (TRC) ($4K) and MCF Advisors LLC ($920).
- Company
- Titan Pharmaceuticals Inc.
- CUSIP
- 888314705
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $5 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 76 shares bought and 4 shares sold, net +72 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| Truist Financial Corp. | 0.00% | No change | 31,255 | $174K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +10.8% | 717 | $4K |
| MCF Advisors LLC | 0.00% | No change | 165 | $920 |
| Bank of America Corp. | 0.00% | Add +41.7% | 17 | $95 |
| Group One Trading LLC | 0.00% | No change | 12 | $66 |
| Osaic Holdings, Inc. | 0.00% | No change | 10 | $54 |
| Morgan Stanley | 0.00% | No change | 3 | $17 |
| Global Wealth Strategies & Associates | 0.00% | No change | 2 | $11 |
| Wells Fargo & Company | 0.00% | Reduce -80.0% | 1 | $6 |
| Caldwell Sutter Capital, Inc. | 0.00% | No change | 1 | $6 |
| St Germain D J Co. Inc. | 0.00% | No change | 1 | $6 |
| Westside Investment Management, Inc. | 0.00% | No change | 1 | $6 |
| UBS Group AG | 0.00% | No change | 1 | $6 |
| NewEdge Advisors, LLC | 0.00% | No change | 1 | $6 |
| Cape Investment Advisory, Inc. | 0.00% | No change | 1 | $6 |
| Nemes Rush Group LLC | 0.00% | No change | 1 | $6 |
| Ransom Advisory, Ltd | 0.00% | No change | 1 | $6 |
| FMR LLC | 0.00% | New | 1 | $5 |
"% of holder's portfolio" is TTNP's weight in each manager's 13F, not the share of Titan Pharmaceuticals Inc. the manager owns.